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Abstract
Background
The SARS-CoV-2 pandemic continues to expand globally, with case numbers rising
in many areas of the world, including the Indian sub-continent. Pakistan has one of
the world’s largest population, of over 200 million people and is experiencing a
severe third wave of infections caused by SARS-CoV-2 that begun in March 2021.In
Pakistan, during third wave until now only 12 SARS-CoV-2 genomes have been
collected and among these 9 are from Islamabad. This highlights the need for more
genome sequencing to allow surveillance of variants in circulation. In fact more
genomes are available among travellers with a travel history from Pakistan, than
from within the country itself.
Methods
For a better understanding of the circulating variants in Lahore and surrounding
areas with a combined population of 11.1 million, within a week of April 2021, 102
samples were sequenced. The samples were randomly collected from  2 hospitals
with a diagnostic polymerase chain reaction (PCR) cutoff value of less than 25
cycles.
Results
Analysis of the lineages shows that B.1.1.7 (first identified in the UK, Alpha variant)
dominates, accounting for 97.9% (97/99) of cases, with B.1.351 (first identified in
South Africa, Beta variant) accounting for 2.0% (2/99) of cases. No other lineages
were observed.
Discussion
In depth analysis of the B.1.1.7 lineages indicates multiple separate introductions
and subsequent establishment within the region. Eight samples were identical to
genomes observed in Europe (7 UK, 1 Switzerland), indicating recent transmission.
Genomes of other samples show evidence that these have evolved, indicating
sustained transmission over a period of time either within Pakistan or other countries
with low density genome sequencing. Vaccines remain effective against B.1.1.7,
however the low level of B.1.351 against which some vaccines are less effective
demonstrates the requirement for continued prospective genomic surveillance.
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Introduction
The COVID-19 pandemic has spread rapidly throughout the world and continues to
expand in many regions. It began with an unknown case of pneumonia in the city of
Wuhan, China (Huang et al., 2020). The causative pathogen has since been named
‘severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2)’. As of May
2021, there have been over 167 million reported cases and 3.4 million fatalities
(Dong, Du and Gardner, 2020). Genomic surveillance has assisted the pandemic
response providing information for outbreak investigations and detecting possible
epitope changes that would allow the virus to escape vaccines. Multiple classification
systems have been developed to quickly communicate SARS-CoV-2 variants
circulating in a community (Alm et al., 2020; Hodcroft et al., 2020; Rambaut et al.,
2020). From these definitions, certain lineages have been designated as Variants of
Concern (VOCs), which are defined as such due to indications of increased
transmission patterns and/or possible resistance to vaccine and/or other treatments
(Volz et al., 2021). World Health Organisation (WHO) has introduced a new
nomenclature of these VOCs and Variants of Interest (VOIs) based on Greek
alphabets.
B.1.1.7 (Alpha) and B.1.351 (Beta) are two VOCs that have circulated globally. The
SARS-CoV-2 lineage B.1.1.7, designated Variant of Concern 202012/01 (VOC) by
Public Health England, was first identified in the UK in late Summer to early Autumn
2020 (Volz et al., 2021). B.1.351 is another VOC identified in South Africa and
defined by eight mutations in the spike protein including (K417N, E484K and N501Y)
(Tegally et al., 2021).
Pakistan is currently experiencing a severe third wave of infections caused by
SARS-CoV-2 which began in March 2021. Vaccination rates nationally are under 2%
(National Command Operation Center, 2021), leaving large segments of the
community at risk of serious illness from COVID-19. Currently very few
SARS-CoV-2 genomes collected in Pakistan are available, with just 12 covering the
third wave, 9 of which are from one city, Islamabad. This highlights the need for more
genome sequencing from Pakistan, particularly given the current situation and the
very high population in order to allow surveillance of variants in circulation. Currently,
more genomes are available for travellers with a travel history from Pakistan, than
from within the country itself (Shu and McCauley, 2017).
We have amplicon sequenced 102 samples, randomly chosen from a 1 week period
in April 2021 from Lahore and surrounding areas, to get a snapshot assessment of
the circulating lineage in the region. This has identified the B.1.1.7 variant of concern
(Alpha) as the primary lineage circulating, found in 97.9% of cases, with clear signals
of repeated overseas introductions into the region.
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Results and Discussion
In this study, from 2021-04-06 to 2021-04-11, 102 SARS-CoV-2 samples in viral
transport medium (VTM)  were randomly selected from SARS-CoV-2 diagnostic
positives by the Mayo Hospital and Sheikh Zayed Hospital in Lahore, Pakistan. All
samples had a Ct < 25. These public hospitals serve a predominantly middle income
population.  The patients were between 21 and 91 years of age with a broad
distribution of ages, with 74% (n=74) male, 26% (n=26) female and 2 unknown. Four
samples were from patients who died (all aged over 60), while all others recovered.
Patients had no history of international travel, with 77 patients explicitly reporting that
they and their household did not recently travel overseas (Supplementary Table S1).
Viral RNA was amplified using the ARTIC protocol (Quick, 2020) with sequencing
libraries prepared using CoronaHiT (Baker et al., 2021). Resulting sequenced reads
were used to generate consensus sequences with the ARTIC bioinformatics protocol
(See methods).
Analysis of the PANGO lineages shows that B.1.1.7 (first identified in the UK)
dominates, accounting for 97.9% (97/99) of cases, with B.1.351 (first identified in
South Africa) accounting for 2.0% (2/99) of cases. No other lineages were observed.
SARS-CoV-2 was first identified in Pakistan on 26th February 2020 (Javed et al.,
2020). The first B.1.1.7 genome was submitted to GISAID on 2020-12-25. There
were previously 268 SARS-CoV-2 genomes available on GISAID where Pakistan
was listed as the country of exposure with 90 assigned as B.1.1.7 or B.1.351  (Table
1; Supplementary Table S2). Most of these samples were associated with
international travel from the country and were collected outside of Pakistan
(Supplementary Table S2). A list of submitting authors of these data can be found in
Supplementary Table S3. We combined all B.1.1.7 and B.1.351 public data with the
genomes presented in this study to provide a snapshot of B.1.1.7 and B.1.351
dissemination (Supplementary Table S4).
Table 1: PANGO lineages of GISAID data where Pakistan is the country of exposure
Lineage Count Lineage Count Lineage Count
B.1.1.7 87 C.23 5 B.1.525 1
B.1.36 35 B.1.36.24 3 C.36 1
B.1 30 A 3 B.1.260 1
B.1.471 24 B 3 B.1.36.8 1
B.1.1.1 18 B.1.351 3 B.1.523 1
B.1.36.31 17 C.11 2 B.1.459 1
B.6 12 B.1.1.370 1 B.1.562 1
B.1.1 10 B.1.36.22 1 B.1.617.1 1
B.1.36.34 5 B.1.1.214 1
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B.1.1.7 was likely introduced into Pakistan as the lineage emerged in the United
Kingdom. B.1.1.7 samples are found in multiple clades spanning the entire
phylogeny of B.1.1.7, suggesting the time to most recent common ancestor of all
B.1.1.7 and B.1.1.7 in Pakistan was similar, which was calculated as October 2020
(Figure 1). The date of emergence of B.1.1.7 is before this date and has been
calculated as September 2020 elsewhere (Galloway et al., 2021). These early
introduction dates into Pakistan are plausible as the first confirmed B.1.1.7 genomes
associated with Pakistan date back as early as late December 2020 (Figure 1).
By reconstructing the exposure history over the phylogenetic tree, we estimate the
number of  B.1.1.7 importations as 127 using the dated tree (Figure 1). More than
half of the introductions into the country happened before March 2021, despite a
constant rate of recent importations. Genomes from Pakistan were intermingled with
genomes from elsewhere, as shown in Figure 2 where we calculated the patristic
distance of genomes in this study to their closest neighbour and found that they were
generally closer to samples from abroad. The number of substitutions to the nearest
neighbour also varied (0-8 substitutions)(Figure 2). Considering that all samples in
this study were sourced from patients with no travel history, this suggests that the
current data does not fully capture transmission within Pakistan. The virus is
detected and sequenced from the source (usually the United Kingdom) and then in
some cases sampled in Pakistan immediately or after several months, where the
number of substitutions were lower or higher respectively.
B.1.351 was likely introduced into Pakistan recently. B.1.351 samples were found in
four clades in the phylogeny of B.1.351, suggesting at least 4 separate introductions
into the country (Figure 3). The time to the most recent common ancestor of B.1.351
globally was calculated here as during September 2020, whereas the clades
containing B.1.351 genomes from Pakistan date no earlier than February 2021
(Figure 3). The date of emergence of B.1.351 is before these dates and has been
calculated as early August 2020 elsewhere (Tegally et al., 2021).
It has been demonstrated (Abu-Raddad, Chemaitelly and Butt, 2021) that vaccines,
in particular BNT162b2, are effective against B.1.1.7. Therefore, if this remains the
dominant lineage in the region, public health vaccination policy can be implemented
accordingly. However, whilst the prevalence of B.1.351, which has been linked to
lower vaccine efficacy, is very low, this reinforces the need for prospective
surveillance of SARS-CoV-2 using genome sequencing to inform public health
interventions in a continual manner.
The most regular source of genomic sequencing is from travellers from Pakistan
being sequenced by their destination countries, and being annotated as such in the
public databases (GISAID). Japan is the largest contributor of  genomes from
travellers originating from Pakistan (111 out of 269). This indirect surveillance is
useful but unreliable as travel restrictions and pre-flight testing can bias the results.
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This report shows the critical importance of whole-genome sequencing of
SARS-CoV-2 to determine the prevalence and changing epidemiology of different
variants of the virus. This data is crucial to inform public health decision makers as
well as to allow global epidemiology to be understood. Building capacity for
sequencing and analysis of genomes in countries with high infection rates will be
crucial for the global response to CoVID-19.
Figure 1: Phylogeny of B.1.1.7 including genomes from Pakistan
At the top, the maximum likelihood dated tree of lineage B.1.1.7, showing only samples close to
sequences related to Pakistan. Branches are coloured red when all descendant tips have Pakistan as
the country of exposure. Samples sequenced in the present study are highlighted as red dots. At the
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bottom we have the histogram of introductions into Pakistan over time, as estimated by ancestral
state reconstruction, with the average time represented by a blue vertical line. Phylogenetic tree was
estimated with IQTREE2 followed by divergence times estimation usingTreeTime after excluding
outliers. The figure was plotted with ggtree and introduction events were estimated with castor.
Figure 2: Distribution of distances to closest neighbours from Pakistan and abroad, for B.1.1.7
sequences.
The number of expected substitutions is calculated from the patristic distances between leaves over
the maximum likelihood tree, transformed from substitutions per site by multiplying by genome length.
For each of the 88 UHS-PAK sequences, we find the closest distance considering only Pakistan (blue)
or international (red) tips on the tree.
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Figure 3: Maximum likelihood dated tree of lineage B.1.351 focused on samples sequenced in
this study.
Branches are coloured according to country of exposure, with Pakistan highlighted with a red circle.
The two samples from the current study, UHS-PAK-S45 and UHS-PAK-S93, are labelled in blue.
Phylogenetic tree was estimated with IQTREE2 (Minh et al., 2020) followed by divergence times
estimation usingTreeTime after excluding outliers. The figure was plotted with ggtree (Yu et al., 2017).
Supplementary data
Supplementary table S1 - Samples sequenced in this study
Supplementary table S2 - GISAID metadata of samples associated with Pakistan
Supplementary Table S3 - GISAID Submitting author information
Supplementary Table S4 - GISAID metadata of B.1.351 and B.1.1.7
Methods
Genome sequencing and analysis
RNA was extracted using Viral RNA Extraction kit, FavorPrep™ and Polymerase
Chain Reaction (RNA) was carried out using GenomeCoV19 Detection Kit by abm
(cat: 628) on IQ 5 bioRad in diagnostic laboratories of Lahore Pakistan. Positive
samples with a CT  < 25 were randomly selected for genome sequencing.  Viral RNA
was converted in cDNA and was amplified using the ARTIC protocol v3 (LoCost)
(Quick, 2020) with sequencing libraries prepared using CoronaHiT (Baker et al.,
2021). We carried out genome sequencing using the Illumina NextSeq 500 platform.
The raw reads were demultiplexed using bcl2fastq (v2.20). The reads were used to
generate a consensus sequence using the ARTIC bioinformatic pipeline (Artic
Network, no date). Briefly, the reads had adapters trimmed with TrimGalore (Krueger,
2020) and were aligned to the WuhanHu-1 reference genome (accession
MN908947.3) using BWA-MEM (v0.7.17) (Li, 2013); the ARTIC amplicons were
trimmed and a consensus built using iVAR (v.1.2.3) (Grubaugh et al., 2019).
PANGO lineages assigned using Pangolin v2.4.2 and PangoLEARN model dated
2021-05-12 (Rambaut et al., 2020).
Phylogenetic analysis
For the phylogenetic analysis, all sequences from GISAID where Pakistan is the
country of exposure were downloaded and added to the sequences from the current
study. All remaining sequences from GISAID were then compared to this data set
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where we kept the closest ones ―for each Pakistan sequence, the four closest from
non-Pakistan were kept for subsequent analysis to provide context. The alignment
and neighbour search were done with uvaia (de Oliveira Martins, Leonardo, 2021),
and problematic (homoplasic or difficult to sequence) sites were masked from the
alignment (Turakhia et al., 2020). For the B.1.1.7 and B.1.351 dated phylogenetic
inference, we further enriched each alignment with more distant neighbours which
maximised the phylogenetic diversity (Minh, Klaere and von Haeseler, 2006), based
on the neighbour-joining tree (Simonsen and Pedersen, 2011) of all sequences close
to each Pakistan sequence, for each lineage. Sequences with more than 10% N, or
with incomplete date information were excluded from analysis. Clusters distant and
unrelated to Pakistan sequences were reduced or removed by visual inspection of
maximum likelihood trees.
From the 102 UHS-PAK sequences, 90 samples were included in the phylogenetic
analysis: 88 from B.1.1.7 and 2 samples from B.1.351; the final alignments have 723
and 107 sequences, respectively. The maximum likelihood trees were inferred with
IQTREE2 v2.1.2 (Minh et al., 2020) and the divergence times were estimated by
marginalisation under a strict clock using TreeTime (Sagulenko, Puller and Neher,
2018). Ancestral state reconstruction of the country of exposure was done with
castor (Louca and Doebeli, 2018) and trees were plotted with ggtree (Yu et al.,
2017), both for R. The number of introductions into Pakistan was estimated by
counting edges where the reconstructed probability of being exposed in Pakistan
increased to one, weighting or not by the number of most parsimonious scenarios.
Due to unequal sampling and sequencing, the number of introductions is an
underestimate and their dates are subject to selection bias (e.g. previous
introductions were not sequenced due to regional differences or severity of
infection).
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